DERM
Journey Medical Corp
NASDAQ · Pharmaceuticals
$8.35
+0.00 (+0.00%)
Open$8.49
Previous Close$8.35
Day High$8.53
Day Low$8.33
52W High$13.91
52W Low$9.60
Volume—
Avg Volume690.6K
Market Cap277.69M
P/E Ratio16.41
EPS$0.73
SectorPharmaceuticals
Analyst Ratings
Strong Buy
10 analysts
Price Target
+87.5% upside
Current
$8.35
$8.35
Target
$15.66
$15.66
$10.95
$15.66 avg
$21.05
Key Financials
| FY 2025 | FY 2024 | FY 2023 | |
|---|---|---|---|
| Revenue | 108.31M | 106.46M | 91.38M |
| Net Income | 14.96M | 19.04M | 15.46M |
| Profit Margin | 13.8% | 17.9% | 16.9% |
| EBITDA | 21.55M | 19.03M | 16.26M |
| Free Cash Flow | 11.63M | 11.82M | 11.85M |
| Rev Growth | +14.5% | +23.5% | +18.8% |
| Debt/Equity | 0.72 | 0.74 | 0.75 |
Pharmaceuticals Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| LLY | Eli Lilly and Co. | $1,058.18 | +3.66% | 48.5 | 1.00T |
| JNJ | Johnson & Johnson | $239.99 | +0.93% | 21.6 | 578.21B |
| MRK | Merck & Co. Inc. | $121.93 | +1.82% | 16.6 | 302.63B |
| PFE | Pfizer Inc. | $27.22 | +2.76% | 19.9 | 154.76B |
| BMY | Bristol-Myers Squibb Co | $61.99 | +4.15% | 17.9 | 126.20B |
| ZTS | Zoetis Inc | $127.42 | +0.54% | 21.5 | 56.95B |